Gefticip 250 mg
Gefticip 250 mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician.
Description Of Gefticip 250mg
Gefticip 250mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.
Gefticip 250mg Chemical Name
Gefticip 250mg Manufacturer
- Cipla Ltd.
Uses of Gefticip 250mg
Gefticip 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
What is Gefticip 250mg?
Gefticip 250mg Tablet is used for Non-small cell lung cancer after failure of platinum and docetaxel chemotherapies, Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and other conditions. Gefticip 250mg Tablet may also be used for purposes not listed in this medication guide.
How Gefticip 250mg working?
Gefticip 250mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
How is Gefticip 250mg used?
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gefticip 250mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Gefticip 250mg Indications
Take Gefticip 250mg Tablet as instructed by the doctor. Do not consume larger quantities than prescribed. It should be used as prescribed by the doctor to prevent the spread of cancer to other parts of the body. Discontinue the treatment if any symptoms of allergic skin reactions appear.
Gefticip 250mg Dosage
- Gefticip 250mg
Contraindication Of Gefticip 250mg
Hypersensitivity to Gefticip 250mg Tablet is a contraindication. In addition, Gefticip 250mg Tablet should not be used if you have the following conditions:
- None reported
Adverse effects Of Gefticip 250mg
- Allergic skin reaction
- Nausea and Vomiting
- Increase in liver enzyme levels
- Eye irritation
- Difficulty in breathing
- Abdominal pain
- Sore throat
- Redness around fingernails
Special Precautions And Related Warnings Of Gefticip 250mg
Gefticip 250mg Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Gefticip 250mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Gefticip 250mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Gefticip 250mg Tablet may be needed. Please consult your doctor.
Gefticip 250mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefticip 250mg Tablet may not be needed in these patients. Please consult your doctor.
Storage Conditions for Gefticip 250mg
Store Gefticip 250mg tablet in a cool and dry place (Not in refrigerator).
Do not leave it in the car. Heat and dampness can destroy some medicines.
Keep this cancer medicine away from the reach of children or pets. A locked cupboard at least one-and-a-half meters above the ground is a good place to store medicines.